International Clinical Trials Day 2026, a year in review: Access to Trials
CLINICAL TRIALS IN REGIONAL, RURAL AND REMOTE AUSTRALIA
With
Amanda Koegelenberg,
CEO, Novatrials
INTERNATIONAL CLINICAL TRIALS DAY SERIES SEGMENT
Filmed in Newcastle, NSW | May 2026
To mark International Clinical Trials Day 2026, Australian Health Journal commences a 4 part special series leading up to 20th May with interviews captured across Australia. Through conversations with leading researchers, clinicians and trial organisations, the series highlights achievements in the year that was for clinical trials. The first segment is an example of how in-person clinical trial access has improved for regional, rural and remote communities.
Novatrials is helping transform access to clinical trials for people living in regional, rural and remote communities across the Hunter New England region and beyond. Based in Newcastle, New South Wales, the organisation was founded with a vision to bring innovative medical treatments closer to communities that have traditionally faced significant travel barriers to access state-of-the-art healthcare.
With the first purpose-built Phase 1 clinical trial facility outside of an Australian capital city, Novatrials is expanding opportunities for participants across Newcastle, the wider Hunter region and regional New South Wales to take part in world-class research closer to home. By conducting Phase 1 through to Phase 4 studies across a range of therapeutic areas, the organisation is helping bridge the gap between laboratory innovation and real-world patient care.
According to CEO Amanda Koegelenberg, the investment in the facility illustrates Novatrials’ commitment to ensuring people in regional and remote areas no longer need to travel vast distances to participate in clinical trials, while also bringing more research investment, innovation and healthcare opportunities into the Hunter New England region.
The segment highlights how Novatrials is working collaboratively with partners including the University of Newcastle, Hunter Medical Research Institute and Hunter New England Local Health District to strengthen the region’s research ecosystem and improve access to emerging treatments for local communities.
Source: Adapted from transcript using AI
-
Mission to raise awareness of sarcoma and need for clinical trial funding
Sarcoma, a rare and aggressive cancer, remains the deadliest cancer for children and young adults, accounting for nearly one third (30%) of cancer-related deaths among those aged 15–24 and one tenth (10%) of those aged 0–14. Further, still severely under-diagnosed, sarcoma only accounts for one sixth (15%) of all cancer diagnoses in the 15 – 24 age group, and less than a tenth (8%) among children under 10.
-
Occupational therapy creates profound impacts on client and patient lives
Margeaux Bartholomew-Carle is an Adelaide based registered Occupational Therapist and the Founder and CEO of Ardant.
Throughout her career, Margeaux has worked in various settings, including aged care, disability, assistive technology, prescription, and mental health. This diverse experience has deepened her understanding of the different needs among client groups.
-
Gavin Fox-Smith talks Medical Technology
Former Johnson & Johnson ANZ Managing Director, Gavin Fox-Smith on working in large & small MedTech companies
